Effects of pharmacogenomic (PGx) testing on clinical pain management prescriptions, a retrospective study
View ORCID ProfileChristian Tagwerker, Mary Jane Carias-Marines, David J. Smith
doi: https://doi.org/10.1101/2021.06.21.21258931
Christian Tagwerker
1Alcala Testing and Analysis Services, 3703 Camino Del Rio South, Suite 100-A, San Diego, California, 92108
Mary Jane Carias-Marines
1Alcala Testing and Analysis Services, 3703 Camino Del Rio South, Suite 100-A, San Diego, California, 92108
David J. Smith
1Alcala Testing and Analysis Services, 3703 Camino Del Rio South, Suite 100-A, San Diego, California, 92108
Posted June 28, 2021.
Effects of pharmacogenomic (PGx) testing on clinical pain management prescriptions, a retrospective study
Christian Tagwerker, Mary Jane Carias-Marines, David J. Smith
medRxiv 2021.06.21.21258931; doi: https://doi.org/10.1101/2021.06.21.21258931
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2298)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11623)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3629)
- Geriatric Medicine (341)
- Health Economics (622)
- Health Informatics (2332)
- Health Policy (919)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3390)
- Nursing (193)
- Nutrition (512)
- Oncology (1777)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1013)
- Primary Care Research (410)
- Public and Global Health (6021)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)